This interview was first published on NZZ on 24 February 2018. Interview by Birgit Voigt NZZ on Sunday: Why is the pharmaceutical industry not developing more new antibiotics? Thomas Cueni: Today, there is simply no economically realistic business model that would justify investments of over one billion Swiss Francs for the development of a...
Read moreRead more
On a TripAdvisor Bangkok forum[1] Gary asks “Can I purchase antibiotics (in Thailand) without a prescription if I run out?”. roverEngland replies: “Yes I get my antibiotics no problem without doctors note in Bangkok. Also they are 1/4 price of what I would pay in UK.”, another writes “Whatever antibiotics you want- Any pharmacies will...
Read moreDelivered by Grega Kumer, Head of DG Office & Legal Issues, IFPMA 25 January 2018 Mr . Chairman. IFPMA members have taken significant steps to implement the GSPA-PHI. We support the global consensus represented by the GSPA-PHI, and its carefully negotiated actions that brought the world together around practical solutions that recognize the...
Read moreThe African Global Health Leaders Fellowship launched to support the future of health in Africa Geneva, 24 January 2018│ The Centre on Global Health Security at Chatham House, the Global Health Centre at the Graduate Institute and the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) announced yesterday the establishment of the 2018-2019 African Global...
Read moreDelivered by Grega Kumer, Head of DG Office & Legal Issues, IFPMA 24 January 2018 Mr. Chairman IFPMA views the discussion on shortages as an issue of paramount importance to ensure sustainable access of patients around the world to the preventive and therapeutic interventions they need. In that light, the discussion...
Read moreThis blog was first published on Life Science Leader on 22 January 2018 As we start 2018, those of us in the healthcare sector are anticipating greater progress in global health. Without a doubt, healthcare has been transformed over the past five decades, through innovation in both prevention and treatment of disease, as well as...
Read moreThe new AMR Industry Alliance of more than 100 biotech, diagnostics, generics and research-based biopharmaceutical companies and trade associations launches its first progress report today. The report measures action taken in four areas: research and science, access, appropriate use, and the environment. In 2016, the report shows that 22 Alliance companies invested at least USD...
Read moreThere is no doubt: Africa will dominate global population dynamics in the 21st century. While public attention has long focused on Asia as a fast-growing and prospering market with currently 4.5 billion inhabitants, today’s one billion sub-Saharan Africans have significantly outpaced Asia in terms of population growth (2.6% vs. 1.1% in 2016, respectively). The main...
Read moreWith new modelling from the Centers for Disease Control and Prevention (CDC) estimating up to 650,000 deaths annually associated with respiratory diseases from seasonal influenza, here I look at the important and on-going role vaccines play in tackling the disease and the innovations helping increase prevention. Influenza, commonly known as flu, is an acute respiratory...
Read more